BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/28/2020 1:08:01 PM | Browse: 1057 | Download: 1774
 |
Received |
|
2020-02-25 19:29 |
 |
Peer-Review Started |
|
2020-02-25 19:30 |
 |
First Decision by Editorial Office Director |
|
2020-04-22 23:06 |
 |
Return for Revision |
|
2020-04-22 23:06 |
 |
Revised |
|
2020-05-02 01:58 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-05-13 07:08 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-05-13 23:11 |
 |
Articles in Press |
|
2020-05-13 23:11 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2020-05-27 09:14 |
 |
Publish the Manuscript Online |
|
2020-05-28 13:08 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Srikanth Vedachalam, Gokulakrishnan Balasubramanian, Garrie J Haas and Somashekar G Krishna |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Somashekar G Krishna, MD, Associate Professor, Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University College of Medicine, 395 W. 12th Avenue, Suite 262, Columbus, OH 43210, United States. somashekar.krishna@osumc.edu |
| Key Words |
Left ventricular assist device; Push enteroscopy; Double balloon enteroscopy; Video capsule endoscopy; Octreotide; Bevacizumab; Gastrointestinal bleeding |
| Core Tip |
Left ventricular assist devices are becoming increasingly common as life-prolonging therapy in advanced heart failure. However, left ventricular assist devices have shown high rates of gastrointestinal bleeding with 18%-40% of patients having episodes of bleed. Arteriovenous malformations are primarily responsible, which can be both challenging to control and cause many patients to discontinue essential anti-platelet and anti-coagulation therapies. Small bowel lesions are common in this population, frequently requiring small bowel endoscopic evaluation. For refractory cases, medical management is required including octreotide, thalidomide, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers, estrogen-based therapies, desmopressin, doxycycline or bevacizumab to prevent further gastrointestinal bleeding. |
| Publish Date |
2020-05-28 13:08 |
| Citation |
Vedachalam S, Balasubramanian G, Haas GJ, Krishna SG. Treatment of gastrointestinal bleeding in left ventricular assist devices: A comprehensive review. World J Gastroenterol 2020; 26(20): 2550-2558 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i20/2550.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i20.2550 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.